Member Info for PM2022

Stand back and watch this fly to 50p son. Bring on Barcelona and 201 then we shall see.

Market cap is only 12 million. Oversold and undervalued.

The next few days. Suzy said it takes a bit of time as they need to get an announcement out at the same time through Barcelona.

Looks 90% this will be good as if it failed we would have known in my opinion. Plenty of time to buy at the lows.

We moved to 60s and 70 on the back of trial results for 201 and potential for a deal. Vals first deal in twenty years for a clinical drug will blow the roof down at this low market cap. The evaluation result is due this week/few days and that should hopefully double us given our MC is only 12 million.

Note also that another drug at pre-clinical stage and 201 completed deal will open the flood gates to allow institutional investment to come and that itself will likely take the share price to recent highs.

As they always say buy low and sell high. Nice opportunity for those that wish to take advantage.

It works:

Surprisingly and unexpectedly, the inventors have now demonstrated that targeting the SH3 domain of the tyrosine kinase, Src impairs the metastatic phenotype of fibrosarcoma and prostate cancer cells. The inventors have found that a peptide that binds to the SH3 domain of Src inhibits EGF-mediated processes known to be collectively involved in metastasis, such as DNA synthesis, motility and MMP secretion (see Example 1), and significantly reduces the incidence of lymph node metastases (see Example 2). Given that cell motility and MMP expression are known to be involved in metastasis (Jung et al, 2010; Cortes et al, 2008; Murray et al, 2012

Great find Mark.

You see my 50p target is not so bad after all. Barcelona first then we see what happens soon after.

Ready to launch.

Lol not if MM is expecting news.

Smart investing is always about being one step ahead. Most rainbow chasers have a lack of understanding and often get caught out. Our time will come possibly this week with Barcelona.

You pay a cheap price for being ahead but those guys will buy much higher.

Most of our pipeline is currently valued at zero but has considerable potential. The market will see this as news flows through and at the moment WITHOUT 201 I believe we should in the 20 s and certainly if Barcelona is successful in the coming days I see no reason for the price moving closer to 30 s without 201 . If it does not happen immediately then it will over a period of time.

The directors are due to go for votes in June to keep their jobs. I see lots of decent outcomes coming to demonstrate the work done over the last three years. They also have options at 25,30 and 40 p which they will want.

1) Suzy confirmed lots of work was being done with VAL 301 in her presentations- A positive early stage outcome for endometriosis will get significant attention as this illness currently has no cure.

2) Barcelona due in the coming days. Taking a second one to the preclinical stage with a potential for an early deal adds great potential and value to our market cap. It will over time attract large investments into the company.

3) CLX001- Our main pre-clinical compound at the moment from Kings College London and early results have shown huge promise and the science is top class which again will attract attention . The project is led by Zia Ahmed who is well known for pre-clinical projects in the industry.

4) VAL201- Deal is ongoing and this can be completed at any moment. Progress has been made and the board remains confident it can be completed soon. This one is worth multiples of our market cap on its own given previous clinical trial outcomes and potential.

5) Hakkaido evaluation due in June. Again this can be our 2nd/3rd or even 4th going into the pre-clinical stage before June.

We should also get updates regarding our new lab and VAL 401 could be a dark horse that finally gets a deal.

Downside remains very limited. I explained my reasons why the drop in our SP was a false down but I expect we will reach fair value or more given the number of different news/outcomes before June most of which is currently valued at ZERO.

I am 100% confident we will be between 30-50 p by June or hit this level at least once. DYOR.

It's not the leak but the potential on offer. A lack of selling and buying as upside remains significant. If Barcelona was unsuccessful it's highly likely we would have known.

A big week. Lets see how it plays out but regardless we have so many options for a decent rise.

I have always said the key is to have two world class compounds at the pre-clinical stage. Now we have CLX001 which is a top shelf compound we all know this and it's worth more than our market cap. The science is brilliant and this drug has attracted the best staff in the industry. Val is actively looking for an early deal which can attract huge upfront payments and milestone payments. We know this from the marketing on Twitter and previous presentations.

We are very undervalued and another compound at pre-clinical will very likely attract significant investment into this company and give us more options such an an early deal at any moment.

WIth a market cap of just 11 million and two world class compounds in pre-clinical should easily take us around the 30p mark. NOTE i am still giving a lead drug VAL201 a value of ZERO and we know the deal for this is ongoing and can be completed at any stage which in itself should take us to multiples of the current market cap but I being negative and giving this an almost zero value. I still believe 201 deal will get done soon though.

At the conclusion of the evaluation period (February 2023), the Company has an option to license the technology on pre-agreed terms but still if Barcelona is good we head right up.

Dr Suzy Dilly, CEO of ValiRx commented: "The lead series of drug candidates under evaluation in this agreement have been developed towards a novel interaction with the KRAS protein important in many cancers of high unmet medical need. KRAS has been a target of interest in oncology for a number of years, and this project has potential to provide a unique method to impact this important pathway."

University of Barcelona research group's Principal Investigator: "KRAS is a known therapeutic target for several cancers, but until recently, it has been undruggable. However, we have found a way to interact with this target. The partnership between University of Barcelona and ValiRx is essential to accelerate the development of those promising results that we have achieved. This agreement will reinforce the project and provide valuable data to progress towards clinical development."

A big few days here. We are oversold and undervalued and this will likely mean a significant rise with any decent news. A great entry level at this price.

We should never be.

Metom you don't need a reason for a rise if you drop from 30/40p and have progressed since then. You should never at the current price we all know this.

it's a lack of selling as nobody is selling at these prices and a few buys. This is a strong buy area not a sell area. Anyway lots of news is due so we shall see what happens this coming week hopefully BIG news from Barcelona due.

Well Metom it's not going to be 15p if Barcelona comes good. It's likely to be much much more. Warrants were only 1/4 and not much and the smallish placing mainly went to sticky hands I heard not through the broker so we should be good for a strong rise.

I believe we will not get many sellers below 20/25p especially if Barcelona is successful as we are so undervalued but likely most will hold for 30/40/50p or more. It often happens in AIM one news is followed by another and hopefully we get lucky with 201 as well and a huge rise.

Has nothing to do with Zak Mir as we moved from 8am Friday not later in the day.

I am a firm believer that undervalued stocks in the AIM market eventually get to fair value or more provided cash flow is managed which with this company it is.

We all need to remember that last year we were steady in the 30s/40s with LOI for 201. The Val201 deal got delayed but Suzy and the team wanted to buy a lab rather than rent one which is what they are doing at the moment. We were cornered into a fairly small fundraise at 10p for working capital as it was last minute due to the delay in the deal completing which is still ongoing. This resulted in a sharp drop but had nothing to do with a drop in valuation although this was the outcome. Therefore it was a FALSE down.

SInce then we have had CLX001 move into pre-clinical stage which we know can attract upfront payments worth more than our market cap and huge milestone payments even at this stage. Valirx is actively marketing this compound regularly on Twitter and who knows they could be negotiating a deal with a number of parties at this moment of time and seeking the best deal. We have also had compounds from Barcelona and Hakkaido in the evaluation stage which again brings value as if any of these move into pre-clinical stage it should add at least 10-15 million to our market cap and increases in value fairly quickly. Our current market cap is only 11 million therefore pricing many of our assets with potential including 301/401 at ZERO.

At this SP the downside remains extremely limited and upside well it depends how long you wish to wait. Personally in a few months I feel Val will get back to 50p if we are stable around 30p which would still be pricing 201 at ZERO and would be based just on our preclinical/evaluation pipeline alone. Any progression with CLX001 with a deal or positive findings regarding pre-clinical data adds huge value as well. This is expected.

Therefore I can understand the desperation by some to keep the price low whilst they seek funds to buy as they see huge value just like I do. BUY with confidence if you feel I am correct if that is what you wish to do but DYOR. At this price it's a great investment in my view and an easy multibagger if things go to plan. We also have working capital for about 12 months as stated in the last presentation.

Note Barcelona is due in February so this week. It's an easy 100% plus from here if successful and if the market reacts how it should with further upside over the coming weeks/months. If not 100% then overtime it should move to fair value and more with further news. A fairly secure investment at this price and time imo. DYOR

Cool Porky. Nothing rampy about it. I am stating it how I see it. Twist it how you want but you seem very frustrated after your losses on DDDD and your taking it out on us as you sold out and purchased that. Leave at that and enjoy your day.

I hold this stock because I believe in the assets and the potential. Mistakes have been made but that has resulted in us being far below fair value by multiples of our current share price.

Now the point that many are missing. Look at the Valirx Twitter account and watch the presentations relating to CLX001 and try to understand the science. Now you will all notice that Valirx advertises this compound very frequently often more than a few times a week. Ask yourself the question WHY ???????????

The reason why CLX001 is advertised again and again is mainly because Valirx are trying to attract the best bid for this compound and to create awareness in the industry. We know the strategy is to out-license all preclinical compounds and we know the value of these types of deals for these compounds can be a few hundred million or even billions in milestone payments with a fairly decent upfront payment of about 10-20 million pounds which can increase drastically as it progresses through the pre-clinical stage.

Suzy has stated in previous presentations they would consider an early bid. Now imagine if Barcelona comes good and suddenly we have two world class pre-clinical projects. This will also attract large investment into the company which will increase the share price significantly over the coming months.

Our market cap is only 10 million. We also have VAL201 which is a phase 2 drug and once the deal completes for this then automatically we would be worth multiples of the current SP. A deal for any one of the pre-clinical compounds at this stage will likely take the SP in excess of 60-70p even before VAL201. We will never know when it happens it will just happen and the SP will open at a new price.

Therefore the fact we have sufficient cash, our assets are worth multiples of our current market cap and the potential for further deals in the coming months I feel we should re-rate to 30-35p comfortably if Barcelona comes good this week. It may not happen in one day but we should ultimately reach this price as fair value with what we have. Therefore at this price the downside is very limited and potential is huge with so many possibilities in the coming weeks/months.

Finally note the staff and directors have options at 25/30-40p. Suzy has 500k options and Kevin 400k if I remember correctly. Now they will want this. Staff will want a bonus and Suzy will grow the company and the SP. I am also reassured that we have Adam Hargreaves as our largest holder as well who can guide the board. Therefore a big buy at these levels is a great buy.

Best wishes.

Since you lost all your money in DDDD you have become nothing but a bitter old man Porky. A time waster. Nobody here posts on your stocks so just relax.

Honestly, investing is not for you. Shouting NYCT £50 then goes to 50p, DDDD 180p goes to 0p, VAL £1 plus and then HE1 a flop. Don't see anything you ever got right. You also were stating res 4 would get passed.

The fact you're so negative about VAL it only serves as a positive here.

Val is well funded and undervalued. You're just making assumptions because once again you miss out. GL and see you in Q2 like you keep telling everyone.

Obvious to everyone you are desperate to buy since you lost your money in DDDD but had you actually done some work in the last 12 months you would of had some money to invest rather than spending time deramping a stock you do no hold. What a loser.

The market has 1000s stocks but we only buy what we believe in and where we see value. If you really do not believe then clear off but I suspect that is not the case.

Since you lost all your money in DDDD you have become nothing but a bitter old man Porky. A time waster. Nobody here posts on your stocks so just relax.

Honestly, investing is not for you. Shouting NYCT £50 then goes to 50p, DDDD 180p goes to 0p, VAL £1 plus and then HE1 a flop. Don't see anything you ever got right. You also were stating res 4 would get passed.

The fact you're so negative about VAL it only serves as a positive here.

Val is well funded and undervalued. You're just making assumptions because once again you miss out. GL and see you in Q2 like you keep telling everyone.

Thank you Porky. I owe this one to you. Going against you is a great strategy. I believe I will make millions betting against you.....

100 % failure what more can anyone ask for lol.